Melike Ak Ayaroğlu

Melike Ak Ayaroğlu

Auto-generated profile, based on publicly available information

Melike Ak Ayaroğlu

Etlik City Hospital

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2026 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
ETEzgi ERDEM TURE
Ezgi ERDEM TURE
MAMelike Ak Ayaroğlu
Melike Ak Ayaroğlu
CKCeren Kılıç
Ceren Kılıç
DDDerya Doğan
Derya Doğan
ADAsena Dikyar
Asena Dikyar
EKEmine Bahar Kurt
Emine Bahar Kurt
Aims: Bronchoalveolar lavage (BAL) is widely used to identify causative pathogens and guide antimicrobial therapy in hematopoietic stem cell transplant (HSCT) recipients; however, the factors associated with microbiological positivity remain poorly defined. This study aimed to evaluate the microbiological diagnostic yield of BAL, its impact on antimicrobial management, and the clinical factors associated with microbiological positivity.Methods: This retrospective observational study included 49 HSCT recipients who underwent 61 bronchoscopic BAL procedures. Demographic, clinical, radiological, laboratory, microbiological, and procedural data were collected from electronic medical records. Clinical characteristics were compared according to BAL microbiological positivity. Univariate and multivariable logistic regression analyses were performed to identify factors associated with microbiological positivity.Results: BAL microbiological positivity was detected in 28 of 61 procedures (45.9%). Ground-glass opacities and consolidation were the predominant chest CT findings. Aspergillus fumigatus complex was the most frequently isolated organism in culture, while galactomannan assay positivity and cytomegalovirus PCR detection were the most common positive microbiological test results. Antimicrobial therapy was modified following bronchoscopy in 29 procedures (47.5%) and occurred significantly more frequently in BAL-positive than BAL-negative cases (64.3% vs. 33.3%, p=0.016). Neither bronchoscopy indication, predominant chest CT pattern, neutropenia, ongoing antimicrobial therapy, nor BAL sample acceptance time was associated with microbiological positivity. Bronchoscopy-related complications occurred in only two procedures (3.3%), both consisting of minor bleeding.Conclusion: BAL provides an acceptable microbiological diagnostic yield with a low complication rate in HSCT recipients and has a substantial impact on antimicrobial management.